Literature DB >> 3862470

Quantitation of HLA-DR expression by cells involved in the skin lesions of tuberculoid and lepromatous leprosy.

L A Collings, N Tidman, L W Poulter.   

Abstract

A method is described which can be used to quantitate class II MHC antigens (HLA-DR) expressed by cells within tissue sections. A mouse anti-human HLA-DR monoclonal antibody is directly conjugated to the fungal enzyme glucose oxidase. The enzyme, in the presence of its substrate can be used to reduce tetrazolium salts to insoluble coloured formazans. The coloured reaction product is proportional to the amount of antigen and can be eluted from cells and measured spectrophotometrically. The application of this technique to a study of the expression of HLA-DR antigens, functionally significant molecules, by mononuclear cells in the cutaneous lesions of leprosy, is described. When a quantitative measure of the HLA-DR expression was related to the area of the granulomata, significant differences in the HLA-DR expression by cells in the infiltrates associated with lesions of tuberculoid and lepromatous leprosy were observed.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3862470      PMCID: PMC1577256     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  11 in total

1.  Evidence that the mechanism of immunological tolerance ("central failure") is operative in the lack of host resistance in lepromatous leprosy.

Authors:  T Godal; B Myrvang; S S Froland; J Shao; G Melaku
Journal:  Scand J Immunol       Date:  1972       Impact factor: 3.487

2.  Immune responsiveness to Mycobacterium leprae and other mycobacterial antigens throughout the clinical and histopathological spectrum of leprosy.

Authors:  B Myrvang; T Godal; D S Ridley; S S Fröland; Y K Song
Journal:  Clin Exp Immunol       Date:  1973-08       Impact factor: 4.330

Review 3.  Role of MHC gene products in immune regulation.

Authors:  B Benacerraf
Journal:  Science       Date:  1981-06-12       Impact factor: 47.728

4.  Antigen-bearing langerhans cells in skin, dermal lymphatics and in lymph nodes.

Authors:  I Silberberg-Sinakin; G J Thorbecke; R L Baer; S A Rosenthal; V Berezowsky
Journal:  Cell Immunol       Date:  1976-08       Impact factor: 4.868

Review 5.  Antigen presenting cells in situ: their identification and involvement in immunopathology.

Authors:  L W Poulter
Journal:  Clin Exp Immunol       Date:  1983-09       Impact factor: 4.330

Review 6.  The regulatory role of macrophages in antigenic stimulation. Part Two: symbiotic relationship between lymphocytes and macrophages.

Authors:  E R Unanue
Journal:  Adv Immunol       Date:  1981       Impact factor: 3.543

7.  Classification of leprosy according to immunity. A five-group system.

Authors:  D S Ridley; W H Jopling
Journal:  Int J Lepr Other Mycobact Dis       Date:  1966 Jul-Sep

8.  Hepatitis B virus and HLA antigen display in the liver during chronic hepatitis B virus infection.

Authors:  L Montano; G C Miescher; A H Goodall; K H Wiedmann; G Janossy; H C Thomas
Journal:  Hepatology       Date:  1982 Sep-Oct       Impact factor: 17.425

9.  Quantitative immunocytochemical localization of pancreatic secretory proteins in subcellular compartments of the rat acinar cell.

Authors:  M Bendayan; J Roth; A Perrelet; L Orci
Journal:  J Histochem Cytochem       Date:  1980-02       Impact factor: 2.479

Review 10.  The human thymic environment.

Authors:  G Janossy; J A Thomas; G Goldstein; F J Bollum
Journal:  Ciba Found Symp       Date:  1981
View more
  9 in total

Review 1.  Immunopathology of leprosy granulomas.

Authors:  R L Modlin; T H Rea
Journal:  Springer Semin Immunopathol       Date:  1988

2.  Defective intralesional interferon-gamma activity in patients with lepromatous leprosy.

Authors:  B Volc-Platzer; H Stemberger; T Luger; T Radaszkiewicz; G Wiedermann
Journal:  Clin Exp Immunol       Date:  1988-02       Impact factor: 4.330

3.  The immunological component of the cellular inflammatory infiltrate in bronchiectasis.

Authors:  J R Silva; J A Jones; P J Cole; L W Poulter
Journal:  Thorax       Date:  1989-08       Impact factor: 9.139

4.  Regulation of macrophage accessory cell activity by mycobacteria. II. In vitro inhibition of Ia expression by Mycobacterium microti.

Authors:  P M Kaye; M Sims; M Feldmann
Journal:  Clin Exp Immunol       Date:  1986-04       Impact factor: 4.330

5.  Defective antigen presentation by Mycobacterium tuberculosis-infected monocytes.

Authors:  J Gercken; J Pryjma; M Ernst; H D Flad
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

6.  The density of HLA-DR antigen expression on alveolar macrophages is increased in pulmonary sarcoidosis.

Authors:  D A Campbell; R M du Bois; R G Butcher; L W Poulter
Journal:  Clin Exp Immunol       Date:  1986-07       Impact factor: 4.330

7.  Effects of treatment on the histopathology of leprosy.

Authors:  I A Cree; G Coghill; A M Subedi; N C Abbot; S R Butlin; P D Samson; J S Beck
Journal:  J Clin Pathol       Date:  1995-04       Impact factor: 3.411

8.  The inhibitory effects of Mycobacterium tuberculosis on MHC class II expression by monocytes activated with riminophenazines and phagocyte stimulants.

Authors:  A A Wadee; R H Kuschke; T G Dooms
Journal:  Clin Exp Immunol       Date:  1995-06       Impact factor: 4.330

9.  The involvement of dendritic cells in the cutaneous lesions associated with tuberculoid and lepromatous leprosy.

Authors:  L A Collings; M F Waters; L W Poulter
Journal:  Clin Exp Immunol       Date:  1985-12       Impact factor: 4.330

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.